balance equationreview2024-12-31
Difference 4724845 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$4.86K
Fiscal year ended 2024-12-31Operating income
-$1.87M
Fiscal year ended 2024-12-31Free cash flow
Unavailable
Fiscal year ended 2024-12-31One World Products, Inc. (OWPC) reported revenue of $4.86K and net income of -$3.94M for the fiscal year ended 2024-12-31. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from One World Products, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.
Income
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Revenue | $4.86K | $7.59K | $125.66K | $38.26K | $59.57K |
| Cost of revenue | $948 | $173.12K | $300.76K | $19.74K | $104.73K |
| Gross profit | $3.92K | -$165.53K | -$175.10K | $18.52K | -$45.16K |
| Operating income | -$1.87M | -$2.08M | -$2.24M | -$3.23M | -$7.92M |
| Net income | -$3.94M | -$3.95M | -$3.06M | -$3.78M | -$7.97M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 106.97M | shares 73.33M | shares 66.19M | Unavailable | Unavailable |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | $-0.04 | $-0.05 | $-0.05 | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $653.98K | $1.29M | $1.59M | $2.29M | $3.96M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | $11.02K | $119.68K | $28.92K |
| Total assets | $68.30K | $98.88K | $3.17M | $2.90M | $1.41M |
| Current assets | $68.30K | $13.88K | $123.47K | $496.99K | $420.62K |
| Total liabilities | $5.26M | $3.87M | $4.22M | $1.72M | $1.86M |
| Current liabilities | $3.17M | $3.87M | $2.23M | $1.52M | $1.70M |
| Total equity incl. NCI | -$9.91M | -$8.35M | -$5.84M | -$3.05M | -$1.95M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | $1.50M |
| Inventory | $16.23K | Unavailable | $54.15K | $198.60K | $267.15K |
| Accounts receivable | $114 | Unavailable | $12.36K | $19.88K | $5.64K |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $594.06K | $528.64K | $798.07K | $480.15K | $734.55K |
Cash flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.12M | -$1.19M | -$1.38M | -$3.73M | -$1.43M |
| Capital expenditures | Unavailable | $5.05K | $43.20K | $393.13K | $62.57K |
| Investing cash flow | -$75.00K | -$5.05K | -$36.85K | -$388.00K | -$62.57K |
| Financing cash flow | $1.28M | $1.06M | $1.32M | $4.22M | $1.27M |
| Net change in cash | $41.73K | -$10.29K | -$108.66K | $90.76K | -$253.46K |
| Stock-based compensation | Unavailable | Unavailable | $339.13K | $133.76K | $3.58M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $0 | $34.27K | $42.29K | $40.32K | $33.61K |
Derived
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Free cash flow | Unavailable | -$1.20M | -$1.42M | -$4.12M | -$1.49M |
| Gross margin | 80.5% | -2181.2% | -139.3% | 48.4% | -75.8% |
| Operating margin | -38494.6% | -27419.6% | -1779.5% | -8444.8% | -13291.6% |
| FCF margin | Unavailable | -15801.5% | -1132.9% | -10772.1% | -2504.2% |
| SBC / revenue | Unavailable | Unavailable | Unavailable | 349.6% | 6007.4% |
| Current ratio | 0.02x | 0.00x | 0.06x | 0.33x | 0.25x |
| Revenue YoY growth | -35.9% | -94.0% | 228.4% | -35.8% | Unavailable |
| Net margin | -80917.4% | -52092.8% | -2434.7% | -9890.7% | -13371.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | 66.5% | 34.4% | 1027.4% | 105.0% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OWPC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-01-02View SEC filing
10-Q · Filed 2025-09-19View SEC filing
10-Q · Filed 2025-06-30View SEC filing
10-K · Filed 2025-06-03View SEC filing
10-Q · Filed 2024-11-14View SEC filing
10-Q · Filed 2024-08-21View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2023-12-31
Difference 4574845 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 4784850 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2021-12-31
Difference 4229845 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.